The diagnosis of primary vitreoretinal lymphoma and central nervous system lymphoma is challenging. In cases with intraocular involvement, vitreous biopsy plays a pivotal role. Several diagnostic tests are employed to confirm a diagnosis and include cytologic evaluation, immunohistochemistry, flow cytometry, and cytokine analysis. The limitations of these conventional diagnostic tests stem from the often paucicellular nature of vitreous biopsy specimens and the fragility of malignant cells ex vivo. Several emerging molecular techniques show promise in improving the diagnostic yield of intraocular biopsy, possibly enabling more accurate and timely diagnoses. This article will review existing diagnostic modalities for intraocular lymphoma, with an emphasis on currently available molecular tests.
CITATION STYLE
Heiferman, M. J., Yu, M. D., & Mruthyunjaya, P. (2022, October 1). Update in Molecular Testing for Intraocular Lymphoma. Cancers. MDPI. https://doi.org/10.3390/cancers14194546
Mendeley helps you to discover research relevant for your work.